Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03295734 · ClinicalTrials.gov registry record · Phase 2
ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension
A Phase 2 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 2
- Development phase
- 223
- Enrollment target
NCT03295734 is a Phase 2 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 223 participants.
The verdict
NCT03295734, a Phase 2 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 223 participants
- Enrollment target
Study Summary
The purpose of this project is to conduct a randomized, controlled trial (RCT) to determine if choice of antihypertensive medication influences changes in functional status and other cardiovascular risk factors among older persons with hypertension when combined with physical exercise.
Interventions
- DRUG Losartan
- BEHAVIORAL Aerobic exercise
- DRUG Perindopril
- DRUG HCTZ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2018-05-29 |
| Est. Completion | 2024-09-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03295734
The ClinicalTrials.gov registry entry for NCT03295734 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Losartan is the first listed.
NCT03295734 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03295734 about?
NCT03295734 is a clinical study titled "ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension". The purpose of this project is to conduct a randomized, controlled trial (RCT) to determine if choice of antihypertensive medication influences changes in functional status and other cardiovascular risk factors among older persons with hypertension when combined with physical exercise.
What is the current status of trial NCT03295734?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 223 participants. The study started on 2018-05-29. Estimated completion is 2024-09-19.
What interventions are being tested in trial NCT03295734?
The interventions under investigation include: Losartan (DRUG), Aerobic exercise (BEHAVIORAL), Perindopril (DRUG), HCTZ (DRUG).
Who is sponsoring clinical trial NCT03295734?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.